INVO Bioscience Earning Date (INVO)

USA |NASDAQ |USD

INVO Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Aug 15, 2022 Jun 2022 - - $-0.17
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Aug 15, 2022 Jun 2022 - - $208.47K

Invo Bioscience's next earnings date is Monday, Aug 15, 2022 for the fiscal quarter ending Jun 2022.

INVO Earnings Date & History Chart

INVO Earnings & Revenue Forecast

INVO Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 2 $-0.32 $-0.55 $-0.09

INVO Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 0 / 0 $-0.32 $-0.03 $-0.03

INVO Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 2 $9.70M $8.75M $10.65M

INVO Earnings Date & Revenue History

INVO Earnings History

|
Show More
Show More

INVO Revenue History

|
Show More
Show More

Invo Bioscience Next Earnings Date & Report

INVO Next Earnings Date & Report Preview: Jun 2022 (FQ)

INVO's next earnings date is Monday, Aug 15, 2022 for the fiscal quarter ending Jun 30, 2022.

Invo Bioscience Previous Earnings Dates & Reports

INVO Previous Earnings Date & Report Recap: Mar 2022 (FQ)

Invo Bioscience's previous earnings date was May 16, 2022 for its fiscal quarter ended Mar 31, 2022.

INVO Previous Earnings Date & Report Recap: Dec 2020 (FY)

Invo Bioscience's previous annual earnings date was Mar 30, 2021 for its fiscal year ended Dec 31, 2020.

INVO's earnings per share (EPS) was $-1.81, missing the consensus analysts forecast of $-0.98 by 84.20% , and lower than the previous year's EPS (Dec 2019) by 167.44%.

Revenues were $1.04M, worse than the forecast of $1.28M by -18.96%, and down by -29.92% from previous year's revenue.

The company reported a net income of $-8.35M.

Invo Bioscience reported a free cash flow of $-4.86M for its fiscal year, compared to $1.26M a year ago.

The company ended the fiscal year with $775.02K in total debt, an increase of 106.14% compared to the previous year.